Led · Series A · Jul 2026

Grace Investment Machine develops financial time-series large models and positions itself as a next-generation self-evolving intelligent-agent investment platform. The company aims to use a multi-agent architecture to create AGI-era investment machines and an asset management platform, seeking to establish a new AI-driven asset management category. It is based in Beijing. Following its recent consecutive angel and angel+ rounds, the company plans to allocate capital to model R&D, build out compute infrastructure, and expand its team. The articles do not disclose revenue, user metrics, or a valuation.

Participated · Equity · Jul 2026

Robotera builds full-stack humanoid robots combining AI "brain" systems, motion control, dexterous hands and humanoid hardware, and positions itself toward logistics and industrial deployments. The company reports beginning deliveries of several thousand units in Q2 2026 and claims deployments in over ten logistics centers across China with partners including SF Group and China Post. Robotera states it has achieved up to 85% of human efficiency in some logistics contexts operating 24/7 and cites a claimed 300% growth rate (no baseline published). Its investor and partner base spans logistics, automotive and consumer electronics players such as SF Group, Geely, Renault (cited as a partner), Alibaba, Samsung, Lenovo and Haier, which the company and articles present as potential channels for further deployments. Financially, the company has raised nearly ¥2.5 billion RMB (~$350M) in total capital following the recent financing, which the company says supports scaling production and broader commercial rollouts. The articles note competition from Western and Chinese robotics firms but highlight Robotera’s operational logistics focus and industrial partnerships as key differentiators.

Participated · Seed · Mar 2026

Excalipoint Therapeutics is a clinical-stage biotechnology company focused on discovering and developing T-cell engager (TCE) therapies for oncology and immunology indications. Its pipeline includes tri- and multi-specific antibody programs such as EXP011 (CTM012) targeting DLL3/CD3/4-1BB—entered Phase I/II with first patient dosed in October 2025—EXP012 (CTM013) targeting CDH17/CD3/4-1BB, and additional programs (EXP016, EXP017, EP101, EXP015) built on its TOPAbody, Immune Shield, and Pro-TCE platform technologies. The company is led by CEO Lei Fang and CFO Jielun Zhu. Following the $68.7M Seed raise, Excalipoint intends to use the funds to advance its proprietary platforms and progress its pipeline programs through clinical development.

Participated · Equity · Jun 2024

紫光展锐 is a platform chip design firm headquartered in Shanghai that claims comprehensive capabilities across 2G/3G/4G/5G, Wi‑Fi, Bluetooth, television tuning and satellite communications. It is one of the few global companies covering full‑scenario communications technologies and is one of three public‑market 5G chip companies. The company splits its business into consumer electronics (5G product line, smartphone line, feature phone line, smart wearable line) and industrial electronics (wide‑area IoT, local IoT, industry intelligent terminals, smart displays, and automotive electronics). The article reports a new financing round and states the board has authorized advancing the round; the company has not disclosed further details. No revenue, user, or other financial metrics were provided in the article. UNISOC is a Chinese fabless semiconductor company. In May it received an increased capital injection of CNY 5 billion and completed an equity restructuring. The company completed registration formalities of change at the Industrial and Commercial Administration on June 8, and its registered capital rose from CNY 4.2 billion to CNY 4.62 billion. The number of shareholders increased from 7 to 31, with Beijing Spreadtrum Investment remaining the largest shareholder at 38.55%, followed by the China National Integrated Circuit Industry Investment Fund (15.27%) and Intel (China) (12.98%). UNISOC's IPO process on the Shanghai Stock Exchange STAR Market is steadily advancing. Industry sources said the rebalanced equity structure is healthier and more conducive to long-term development. Spreadtrum Communications Inc. is a Sunnyvale, Calif.–based maker of wireless chipsets and maintains offices in China. The company designs and sells wireless chipset products for mobile and wireless devices. According to a regulatory filing cited by PE Week wire, Spreadtrum has secured $10 million of a $20 million Series D round. The filing named no lead investor for the tranche. Return backers in the round include Fortune Venture Group and New Enterprise Associates. The article does not disclose operating metrics, revenue, or additional financial details.

Participated · Series C · Jan 2024

Meishubao, founded in 2014, began as an online platform connecting high-school art students and art training institutions. It offers online courses, painting critique, and information on art colleges, and has expanded into Meishubao 1to1 for children aged 4–12. The company also provides Microschool, a SaaS product for art training institutions, aiming to build a comprehensive art education network in China. Meishubao plans to add one-to-many classes and AR animation courses this summer. Operating metrics cited include a teacher wage cost reduced to 30% of per-customer transaction, online course pricing at CNY 100 (50–70% of offline class price), and a free-trial conversion rate of approximately 30%. Founder Gan Ling projected the company would make a profit of CNY 700 million in 2019. Meishubao Education is a Chinese online art education platform. The company is backed by Tencent. It focuses on delivering art education courses and services online. It announced the completion of a Series D round of financing at $210 million. The financing round was led by TPG’s global impact investing platform, The Rise Fund. The company made the announcement on Thursday.